Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SOPHiA GENETICS S.A. (SOPH)
USD5.78
+0.10 (+1.76%)
CH NASDAQ Healthcare Medical - Healthcare Information Services
Address
Rue du Centre 172 1025
Rolle, CH
Rolle, CH
CEO
Jurgi Camblong
Website
sophiagenetics.com
IPO
2021-07-23
CIK 1840706 ISIN CH1125843347
Description
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.78
+0.10 (+1.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
153.5K
Beta
0.99
Float Shares
51.58M
Free Float %
72.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.34% | -14.58% | -4.54% | -2.32% | +5.71% | -0.86% | +48.40% | +3.81% | -72.37% | -72.37% | -72.37% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
5.78
Low
7.00
+21.1%
Consensus
7.50
+29.8%
Median
7.50
+29.8%
High
8.00
+38.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
8.00
+38.4%
|
| Last Quarter | 2 |
7.50
+29.8%
|
| Last Year | 3 |
7.33
+26.8%
|
| All Time | 7 |
6.29
+8.8%
|
Quality scores
Altman Z-Score
-3.63
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+18.6% ★ Q1'26: +22.0% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%-23.2% Q1'26: -3.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-72.9% Q1'26: -78.6% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-91.8% Q1'26: -79.7% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-177.9% Q1'26: -161.8% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+2.7% Q1'26: +6.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-1.03× Q1'26: -1.07× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
40.45M
est: 40.89M (-1.1%)
|
47.56M
est: 47.05M (+1.1%)
|
62.37M
est: 64.94M (-4.0%)
|
65.17M
est: 65.14M (+0.0%)
|
77.27M
est: 76.20M (+1.4%)
|
93.40M
92.24M – 94.32M
+22.6% YoY
|
112.38M
109.10M – 114.70M
+20.3% YoY
|
140.20M
138.46M – 141.58M
+24.8% YoY
|
173.90M
171.75M – 175.61M
+24.0% YoY
|
236.80M
233.87M – 239.13M
+36.2% YoY
|
| EBITDA |
-69.24M
est: -39.08M (-77.2%)
|
-81.38M
est: -44.97M (-80.9%)
|
-69.57M
est: -59.40M (-17.1%)
|
-50.76M
est: -59.58M (+14.8%)
|
-61.40M
est: -69.70M (+11.9%)
|
-85.43M
-86.27M – -84.37M
-22.6% YoY
|
-102.79M
-104.91M – -99.79M
-20.3% YoY
|
-128.24M
-129.50M – -126.65M
-24.8% YoY
|
-159.06M
-160.63M – -157.09M
-24.0% YoY
|
-216.60M
-218.72M – -213.91M
-36.2% YoY
|
| EBIT |
-72.85M
est: -40.16M (-81.4%)
|
-86.95M
est: -46.21M (-88.1%)
|
-77.91M
est: -62.71M (-24.2%)
|
-59.36M
est: -62.91M (+5.6%)
|
-70.93M
est: -73.59M (+3.6%)
|
-90.20M
-91.08M – -89.08M
-22.6% YoY
|
-108.52M
-110.77M – -105.36M
-20.3% YoY
|
-135.39M
-136.72M – -133.72M
-24.8% YoY
|
-167.94M
-169.59M – -165.86M
-24.0% YoY
|
-228.68M
-230.93M – -225.85M
-36.2% YoY
|
| Net Income |
-73.68M
est: -87.93M (+16.2%)
|
-87.45M
est: -93.78M (+6.7%)
|
-78.98M
est: -68.88M (-14.7%)
|
-62.49M
est: -59.79M (-4.5%)
|
-79.00M
est: -75.35M (-4.8%)
|
-58.49M
-59.34M – -57.65M
+22.4% YoY
|
-44.16M
-44.80M – -43.53M
+24.5% YoY
|
-32.35M
-34.45M – -26.34M
+26.8% YoY
|
-10.81M
-10.94M – -10.63M
+66.6% YoY
|
27.02M
26.58M – 27.36M
+350.0% YoY
|
| SGA |
70.24M
est: 59.43M (+18.2%)
|
84.08M
est: 68.39M (+22.9%)
|
81.72M
est: 92.06M (-11.2%)
|
76.32M
est: 92.34M (-17.4%)
|
85.17M
est: 108.02M (-21.2%)
|
132.40M
130.76M – 133.70M
+22.6% YoY
|
159.30M
154.66M – 162.60M
+20.3% YoY
|
198.75M
196.28M – 200.70M
+24.8% YoY
|
246.52M
243.47M – 248.94M
+24.0% YoY
|
335.69M
331.53M – 338.98M
+36.2% YoY
|
| EPS |
-1.33
est: -1.34 (+0.5%)
|
-1.36
est: -1.43 (+4.6%)
|
-1.22
est: -1.02 (-19.4%)
|
-0.95
est: -0.89 (-7.1%)
|
-1.17
est: -1.12 (-4.7%)
|
-0.87
-0.88 – -0.85
+22.4% YoY
|
-0.66
-0.66 – -0.64
+24.5% YoY
|
-0.45
-0.51 – -0.39
+31.3% YoY
|
-0.16
-0.16 – -0.16
+64.4% YoY
|
0.40
0.39 – 0.41
+350.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | BTIG | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-40.99M
OE per share TTM
-0.59
Owner's Yield
-10.67%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
31.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
11
Total invested
16.05M
Insider transactions (90d)
8
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Alychlo N.V. | 6.99M | 11.00% | — | 6.99M | — | 6.99M | CO | Belgium | 2022-02-14 | ↗ |
| 2 | Marc Coucke | 6.99M | 11.00% | — | 6.99M | — | 6.99M | IN | Belgium | 2022-02-14 | ↗ |
| 3 | Generation IM Sustainable Solutions Fund III, L.P. | 6.79M | 10.60% | — | 6.79M | — | — | OO | England and Wales | 2022-02-15 | ↗ |
| 4 | Generation IM Sustainable Solutions GP III Limited | 6.79M | 10.60% | — | 6.79M | — | — | OO | England and Wales | 2022-02-15 | ↗ |
| 5 | Generation IM Sustainable Solutions III, GP Ltd | 6.79M | 10.60% | — | 6.79M | — | — | OO | Guernsey | 2022-01-06 | ↗ |
| 6 | Generation Investment Management LLP | 6.79M | 10.60% | — | 6.79M | — | — | IA | England and Wales | 2022-02-15 | ↗ |
| 7 | Balderton Capital General Partner VI, S.á.r.l. | 3.36M | 5.30% | — | 3.36M | — | 3.36M | FI | — | 2022-02-10 | ↗ |
| 8 | Balderton Capital VI, S.L.P. | 3.36M | 5.30% | — | 3.36M | — | 3.36M | PN | — | 2022-02-10 | ↗ |
| 9 | Dr. Yair C. Schindel | 3.21M | 5.00% | — | 3.21M | — | 10.00 | IN | Israel | 2023-01-10 | ↗ |
| 10 | aMoon General Partner Ltd. | 3.19M | 4.97% | — | 3.19M | — | 10.00 | CO | Israel | 2023-01-10 | ↗ |
| 11 | aMoon Growth Fund G.P. Limited Partnership | 3.19M | 4.97% | — | 3.19M | — | 10.00 | PN | Israel | 2023-01-10 | ↗ |
| 12 | aMoon Growth Fund Limited Partnership | 3.19M | 4.97% | — | 3.19M | — | 10.00 | PN | Cayman Islands | 2023-01-10 | ↗ |
| 13 | Berko Capital Ltd. | 19.0K | 0.03% | — | 19.0K | — | 10.00 | CO | Israel | 2023-01-10 | ↗ |
| 14 | Dr. Tomer Berkovitz | 19.0K | 0.03% | — | 19.0K | — | 10.00 | IN | Israel | 2023-01-10 | ↗ |
| 15 | Hilliyon Holdings Ltd. | 19.0K | 0.03% | — | 19.0K | — | 10.00 | CO | Israel | 2023-01-10 | ↗ |
| 16 | aMoon Edge GP Ltd. | 19.0K | 0.03% | — | 19.0K | — | 10.00 | CO | Cayman Islands | 2023-01-10 | ↗ |
| 17 | aMoon Edge Limited Partnership | 19.0K | 0.03% | — | 19.0K | — | 10.00 | PN | Cayman Islands | 2023-01-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
11
-31 vs prev Q
New positions
3
Closed positions
34
Increased
6
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GENERATION INVESTMENT MANAGEMENT LLP | 6.79M +— (+0.0%) | 31.71M -611.1K (-1.9%) | 10.02% -0.070 pp | 0.22% +0.006 pp | USD17.53 -73.4% | 18 qtrs — |
| 2 | AKRE CAPITAL MANAGEMENT LLC | 3.72M +— (+0.0%) | 17.37M -334.7K (-1.9%) | 5.49% -0.038 pp | 0.19% +0.014 pp | USD3.96 +17.9% | 8 qtrs — |
| 3 | BANQUE PICTET & CIE SA | 2.21M +— (+0.0%) | 10.31M -198.7K (-1.9%) | 3.26% -0.023 pp | 0.06% -0.001 pp | USD7.35 -36.5% | 16 qtrs — |
| 4 | ALTA WEALTH ADVISORS LLC | 1.41M +— (+0.0%) | 6.58M -126.8K (-1.9%) | 2.08% -0.014 pp | 2.20% -0.204 pp | USD4.76 -1.9% | 15 qtrs — |
| 5 | PRINCIPAL FINANCIAL GROUP INC | 1.40M +8.2K (+0.6%) | 6.54M -86.8K (-1.3%) | 2.06% -0.002 pp | 0.00% +0.000 pp | USD9.02 -48.2% | 18 qtrs — |
| 6 | ARCHON CAPITAL MANAGEMENT LLC | 441.4K +14.3K (+3.4%) | 2.06M +28.5K (+1.4%) | 0.65% +0.017 pp | 1.17% -0.038 pp | USD3.55 +31.5% | 3 qtrs — |
| 7 | ROYCE & ASSOCIATES LP | 430.3K +430.3K (+100.0%) | 2.01M +2.0M (+100.0%) | 0.63% +0.635 pp | 0.02% +0.020 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 8 | PICTET & CIE (EUROPE) SA | 255.2K +— (+0.0%) | 1.19M -23.0K (-1.9%) | 0.38% -0.003 pp | 0.02% -0.001 pp | USD7.17 -34.9% | 16 qtrs — |
| 9 | 1492 CAPITAL MANAGEMENT LLC | 208.3K +208.3K (+100.0%) | 973.0K +973.0K (+100.0%) | 0.31% +0.307 pp | 0.37% +0.373 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 10 | EDMOND DE ROTHSCHILD HOLDING S.A. | 203.3K +— (+0.0%) | 949.6K -18.3K (-1.9%) | 0.30% -0.002 pp | 0.01% -0.002 pp | USD3.67 +27.2% | 15 qtrs — |
| 11 | FEDERATED HERMES, INC. | 187.7K -22.3K (-10.6%) | 876.5K -123.1K (-12.3%) | 0.28% -0.035 pp | 0.00% 0.000 pp | USD3.26 +43.3% | 13 qtrs — |
| 12 | ENSIGN PEAK ADVISORS, INC | 182.4K -12.8K (-6.5%) | 851.9K -77.2K (-8.3%) | 0.27% -0.021 pp | 0.00% +0.000 pp | USD3.10 +50.6% | 3 qtrs — |
| 13 | RATHBONES GROUP PLC | 160.1K -2.4K (-1.4%) | 747.8K -25.6K (-3.3%) | 0.24% -0.005 pp | 0.00% 0.000 pp | USD3.10 +50.6% | 3 qtrs — |
| 14 | MILLENNIUM MANAGEMENT LLC | 125.5K -100.4K (-44.5%) | 585.9K -489.4K (-45.5%) | 0.19% -0.151 pp | 0.00% 0.000 pp | USD4.19 +11.5% | 18 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 92.6K +680.0 (+0.7%) | 432.4K -5.1K (-1.2%) | 0.14% +0.000 pp | 0.00% +0.000 pp | USD6.03 -22.6% | 17 qtrs — |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 83.0K +52.2K (+169.5%) | 387.6K +241.0K (+164.4%) | 0.12% +0.077 pp | 0.00% +0.000 pp | USD4.44 +5.2% | 15 qtrs — |
| 17 | UBS GROUP AG | 61.9K +46.5K (+302.4%) | 289.1K +215.9K (+294.8%) | 0.09% +0.069 pp | 0.00% +0.000 pp | USD4.62 +1.1% | 18 qtrs — |
| 18 | MORGAN STANLEY | 48.0K +6.5K (+15.7%) | 224.4K +26.7K (+13.5%) | 0.07% +0.009 pp | 0.00% +0.000 pp | USD4.07 +14.7% | 18 qtrs — |
| 19 | SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 47.8K +1.1K (+2.4%) | 223.3K +933.0 (+0.4%) | 0.07% +0.001 pp | 0.13% -0.006 pp | USD3.21 +45.5% | 5 qtrs — |
| 20 | GREEN ALPHA ADVISORS, LLC | 45.7K +4.4K (+10.8%) | 213.2K +17.0K (+8.7%) | 0.07% +0.006 pp | 0.20% +0.006 pp | USD3.46 +35.0% | 6 qtrs — |
| 21 | PATHSTONE HOLDINGS, LLC | 32.2K +88.0 (+0.3%) | 150.4K -2.5K (-1.6%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD3.28 +42.4% | 6 qtrs — |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30.5K +12.0K (+65.1%) | 142.5K +54.5K (+62.0%) | 0.05% +0.018 pp | 0.00% +0.000 pp | USD4.72 -1.1% | 2 qtrs — |
| 23 | GOLDMAN SACHS GROUP INC | 28.7K +1.5K (+5.3%) | 133.8K +4.3K (+3.3%) | 0.04% +0.002 pp | 0.00% +0.000 pp | USD3.69 +26.6% | 3 qtrs — |
| 24 | GSA CAPITAL PARTNERS LLP | 25.0K +12.5K (+100.5%) | 117.0K +58.0K (+98.3%) | 0.04% +0.018 pp | 0.01% +0.005 pp | USD4.71 -0.8% | 2 qtrs — |
| 25 | POLEN CAPITAL MANAGEMENT LLC | 21.7K +21.7K (+100.0%) | 101.5K +101.5K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.000 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 26 | FNY INVESTMENT ADVISERS, LLC | 16.0K -28.7K (-64.2%) | 74.0K -138.0K (-65.1%) | 0.02% -0.043 pp | 0.02% -0.047 pp | USD4.76 -1.9% | 4 qtrs — |
| 27 | XTX TOPCO LTD | 11.8K +11.8K (+100.0%) | 54.9K +54.9K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.001 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 28 | QUADRATURE CAPITAL LTD | 11.6K +11.6K (+100.0%) | 54.4K +54.4K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.001 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 29 | PERKINS CAPITAL MANAGEMENT INC | 10.5K +10.5K (+100.0%) | 49.0K +49.0K (+100.0%) | 0.02% +0.016 pp | 0.04% +0.039 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 30 | ACADIAN ASSET MANAGEMENT LLC | 5.9K +5.9K (+100.0%) | 27.0K +27.0K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 31 | BANK OF AMERICA CORP /DE/ | 5.6K +5.6K (+100.0%) | 25.9K +25.9K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 32 | BLACKROCK, INC. | 5.1K +— (+0.0%) | 23.8K -457.0 (-1.9%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.67 +27.2% | 6 qtrs — |
| 33 | ASSETMARK, INC | 4.7K +566.0 (+13.7%) | 21.9K +2.3K (+11.6%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD4.53 +3.1% | 16 qtrs — |
| 34 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 3.8K -3.2K (-45.8%) | 17.5K -15.4K (-46.8%) | 0.01% -0.005 pp | 0.00% +0.000 pp | USD4.21 +10.9% | 18 qtrs — |
| 35 | COMPAGNIE LOMBARD ODIER SCMA | 1.1K +— (+0.0%) | 4.9K -95.0 (-1.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.27 +105.7% | 14 qtrs — |
| 36 | ADVISOR GROUP HOLDINGS, INC. | 1.0K +853.0 (+580.3%) | 4.7K +4.0K (+567.1%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD4.59 +1.7% | 3 qtrs — |
| 37 | ROYAL BANK OF CANADA | 600.00 +— (+0.0%) | 3.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.71 -0.8% | 9 qtrs — |
| 38 | PNC FINANCIAL SERVICES GROUP, INC. | 370.00 +370.0 (+100.0%) | 1.7K +1.7K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD4.67 +0.0% | 1 qtrs NEW |
| 39 | — | 170.00 +170.0 (+100.0%) | 794.00 +794.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD4.66 +0.2% | 1 qtrs NEW |
| 40 | RUSSELL INVESTMENTS GROUP, LTD. | 59.00 +37.0 (+168.2%) | 276.00 +171.0 (+162.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.58 +2.0% | 11 qtrs — |
| 41 | SBI SECURITIES CO., LTD. | 41.00 +40.0 (+4,000.0%) | 191.00 +186.0 (+3,720.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.63 +0.9% | 2 qtrs — |
| 42 | SIMPLEX TRADING, LLC | 31.00 -995.0 (-97.0%) | 144.00 -3.9K (-96.4%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD4.74 -1.5% | 2 qtrs — |
| 43 | SQUAREPOINT OPS LLC | — -10.2K (-100.0%) | — -48.7K (-100.0%) | 0.00% -0.015 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 44 | PRINCIPAL SECURITIES, INC. | — -394.0 (-100.0%) | — -1.9K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 9 qtrs SOLD |
| 45 | THOMPSON SIEGEL & WALMSLEY LLC | — -29.8K (-100.0%) | — -142.0K (-100.0%) | 0.00% -0.044 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 46 | TOWER RESEARCH CAPITAL LLC (TRC) | — -491.0 (-100.0%) | — -2.3K (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 47 | CITADEL ADVISORS LLC | — -12.3K (-100.0%) | — -58.6K (-100.0%) | 0.00% -0.018 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 48 | DIMENSIONAL FUND ADVISORS LP | — -31.3K (-100.0%) | — -148.2K (-100.0%) | 0.00% -0.047 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 49 | SAVVY ADVISORS, INC. | — -10.0K (-100.0%) | — -47.6K (-100.0%) | 0.00% -0.015 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 50 | GROUPE LA FRANCAISE | — -120.0 (-100.0%) | — -569.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Harbor Health Care ETF (MEDI) MEDI | 0.32% | 138.0K | 0.80% |
| 2 | Fidelity Nasdaq Composite Index ETF ONEQ | 0.00% | 323.3K | 0.21% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.48
Bearish
Ratio by volume
3.00
Bullish
Buys
27
Sells
56
Shares acquired
5.22M
Shares disposed
190.1K
Cash buys
—
Cash sales
56.00
Net activity
+5,028,975
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 5,000 | 4.82 | 24.1K | 261,388 | D | ↗ |
| 2026-04-20 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 608 | 5.21 | 3.2K | 630,888 | D | ↗ |
| 2026-04-20 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 684 | 5.20 | 3.6K | 345,736 | D | ↗ |
| 2026-04-20 | Valente Manuela | Officer | S-Sale | D | Ordinary Shares | 380 | 5.20 | 2.0K | 215,071 | D | ↗ |
| 2026-04-20 | Puylaert Kevin | Officer | S-Sale | D | Ordinary Shares | 33 | 5.08 | 167.69 | 148,197 | D | ↗ |
| 2026-04-20 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 760 | 5.20 | 4.0K | 681,672 | D | ↗ |
| 2026-04-20 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 608 | 5.20 | 3.2K | 266,388 | D | ↗ |
| 2026-04-20 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 4,486 | 5.21 | 23.3K | 3,642,481 | D | ↗ |
| 2026-04-15 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 17,473 | 5.00 | 87.4K | 3,646,967 | D | ↗ |
| 2026-04-14 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 600 | 4.97 | 3.0K | 631,496 | D | ↗ |
| 2026-04-14 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 2,800 | 4.96 | 13.9K | 682,432 | D | ↗ |
| 2026-04-14 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 1,600 | 4.96 | 7.9K | 266,996 | D | ↗ |
| 2026-04-14 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 43,129 | 4.96 | 213.8K | 3,664,440 | D | ↗ |
| 2026-04-13 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 3,400 | 4.76 | 16.2K | 632,096 | D | ↗ |
| 2026-04-13 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 4,442 | 4.77 | 21.2K | 685,232 | D | ↗ |
| 2026-04-13 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 3,400 | 4.76 | 16.2K | 268,596 | D | ↗ |
| 2026-04-13 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 4,399 | 4.76 | 21.0K | 3,707,569 | D | ↗ |
| 2026-04-10 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 3,706 | 4.68 | 17.3K | 636,510 | D | ↗ |
| 2026-04-10 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 2,400 | 4.67 | 11.2K | 346,420 | D | ↗ |
| 2026-04-10 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 3,687 | 4.69 | 17.3K | 689,674 | D | ↗ |
| 2026-04-10 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 3,725 | 4.68 | 17.4K | 272,996 | D | ↗ |
| 2026-04-10 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 8,500 | 4.72 | 40.1K | 3,715,700 | D | ↗ |
| 2026-04-09 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 1,936 | 4.74 | 9.2K | 640,216 | D | ↗ |
| 2026-04-09 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 1,988 | 4.74 | 9.4K | 348,820 | D | ↗ |
| 2026-04-09 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 1,950 | 4.74 | 9.2K | 693,361 | D | ↗ |
| 2026-04-09 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 1,931 | 4.74 | 9.2K | 276,721 | D | ↗ |
| 2026-04-09 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 1,950 | 4.74 | 9.2K | 3,724,200 | D | ↗ |
| 2026-04-08 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 2,800 | 4.84 | 13.5K | 642,152 | D | ↗ |
| 2026-04-08 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 2,861 | 4.85 | 13.9K | 350,808 | D | ↗ |
| 2026-04-08 | Valente Manuela | Officer | S-Sale | D | Ordinary Shares | 3,824 | 4.85 | 18.5K | 215,451 | D | ↗ |
| 2026-04-08 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 2,786 | 4.84 | 13.5K | 695,311 | D | ↗ |
| 2026-04-08 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 2,800 | 4.84 | 13.5K | 278,652 | D | ↗ |
| 2026-04-08 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 2,800 | 4.84 | 13.6K | 3,726,150 | D | ↗ |
| 2026-04-08 | CARDOZA GEORGE | Officer | S-Sale | D | Ordinary Shares | 1,403 | 4.85 | 6.8K | 291,458 | D | ↗ |
| 2026-04-07 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 2,400 | 4.87 | 11.7K | 644,952 | D | ↗ |
| 2026-04-07 | Verma Abhimanyu | Officer | S-Sale | D | Ordinary Shares | 1,030 | 4.87 | 5.0K | 204,400 | D | ↗ |
| 2026-04-07 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 2,400 | 4.87 | 11.7K | 353,669 | D | ↗ |
| 2026-04-07 | Valente Manuela | Officer | S-Sale | D | Ordinary Shares | 2,376 | 4.87 | 11.6K | 219,275 | D | ↗ |
| 2026-04-07 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 2,424 | 4.87 | 11.8K | 698,097 | D | ↗ |
| 2026-04-07 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 2,400 | 4.87 | 11.7K | 281,452 | D | ↗ |
| 2026-04-07 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 2,500 | 4.86 | 12.2K | 3,728,950 | D | ↗ |
| 2026-04-07 | CARDOZA GEORGE | Officer | S-Sale | D | Ordinary Shares | 2,413 | 4.88 | 11.8K | 292,861 | D | ↗ |
| 2026-04-06 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 2,700 | 4.85 | 13.1K | 647,352 | D | ↗ |
| 2026-04-06 | Verma Abhimanyu | Officer | S-Sale | D | Ordinary Shares | 2,519 | 4.86 | 12.2K | 205,430 | D | ↗ |
| 2026-04-06 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 2,705 | 4.86 | 13.1K | 356,069 | D | ↗ |
| 2026-04-06 | Valente Manuela | Officer | S-Sale | D | Ordinary Shares | 2,597 | 4.85 | 12.6K | 221,651 | D | ↗ |
| 2026-04-06 | Puylaert Kevin | Officer | S-Sale | D | Ordinary Shares | 30 | 4.83 | 144.90 | 148,230 | D | ↗ |
| 2026-04-06 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 2,600 | 4.85 | 12.6K | 700,521 | D | ↗ |
| 2026-04-06 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 2,700 | 4.85 | 13.1K | 283,852 | D | ↗ |
| 2026-04-06 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 2,600 | 4.85 | 12.6K | 3,731,450 | D | ↗ |
| 2026-04-06 | CARDOZA GEORGE | Officer | S-Sale | D | Ordinary Shares | 2,520 | 4.85 | 12.2K | 295,274 | D | ↗ |
| 2026-04-02 | Xu Zhenyu | Officer | A-Award | A | Share Option (Right to Buy) | 164,671 | 5.04 | 829.9K | 164,671 | D | ↗ |
| 2026-04-02 | Verma Abhimanyu | Officer | A-Award | A | Ordinary Shares | 82,136 | 0.00 | — | 82,136 | D | ↗ |
| 2026-04-02 | Van Well Daan | Officer | A-Award | A | Share Option (Right to Buy) | 142,216 | 5.04 | 716.8K | 142,216 | D | ↗ |
| 2026-04-02 | Valente Manuela | Officer | A-Award | A | Share Option (Right to Buy) | 104,790 | 5.04 | 528.1K | 104,790 | D | ↗ |
| 2026-04-02 | Puylaert Kevin | Officer | A-Award | A | Ordinary Shares | 56,468 | 0.00 | — | 56,468 | D | ↗ |
| 2026-04-02 | Muken Ross | Officer | A-Award | A | Share Option (Right to Buy) | 628,743 | 5.04 | 3.17M | 628,743 | D | ↗ |
| 2026-04-02 | Menu Philippe | Officer | A-Award | A | Share Option (Right to Buy) | 164,671 | 5.04 | 829.9K | 164,671 | D | ↗ |
| 2026-04-02 | Camblong Jurgi | Director / Officer | A-Award | A | Share Option (Right to Buy) | 628,743 | 5.04 | 3.17M | 628,743 | D | ↗ |
| 2026-04-02 | CARDOZA GEORGE | Officer | A-Award | A | Ordinary Shares | 112,936 | 0.00 | — | 112,936 | D | ↗ |
| 2026-03-31 | Puylaert Kevin | Officer | S-Sale | D | Ordinary Shares | 3 | 4.71 | 14.13 | 92,383 | D | ↗ |
| 2026-03-19 | Xu Zhenyu | Officer | S-Sale | D | Ordinary Shares | 608 | 4.78 | 2.9K | 537,116 | D | ↗ |
| 2026-03-19 | Van Well Daan | Officer | S-Sale | D | Ordinary Shares | 684 | 4.79 | 3.3K | 261,238 | D | ↗ |
| 2026-03-19 | Valente Manuela | Officer | S-Sale | D | Ordinary Shares | 380 | 4.79 | 1.8K | 152,379 | D | ↗ |
| 2026-03-19 | Puylaert Kevin | Officer | S-Sale | D | Ordinary Shares | 33 | 4.76 | 157.08 | 92,386 | D | ↗ |
| 2026-03-19 | Muken Ross | Officer | S-Sale | D | Ordinary Shares | 1,183 | 4.79 | 5.7K | 271,910 | D | ↗ |
| 2026-03-19 | Menu Philippe | Officer | S-Sale | D | Ordinary Shares | 608 | 4.79 | 2.9K | 173,616 | D | ↗ |
| 2026-03-19 | Camblong Jurgi | Director / Officer | S-Sale | D | Ordinary Shares | 4,486 | 4.77 | 21.4K | 3,302,839 | D | ↗ |
| 2026-03-19 | CARDOZA GEORGE | Officer | S-Sale | D | Ordinary Shares | 774 | 4.79 | 3.7K | 184,858 | D | ↗ |
| 2026-03-18 | Xu Zhenyu | Officer | — | — | Share Option (Right to Buy) | 10,000 | 3.28 | 32.8K | 0 | D | ↗ |
| 2026-03-18 | Verma Abhimanyu | Officer | — | — | Share Option (Right to Buy) | 130,112 | 4.72 | 614.1K | 0 | D | ↗ |
| 2026-03-18 | Van Well Daan | Officer | — | — | Share Option (Right to Buy) | 2,500 | 3.93 | 9.8K | 0 | D | ↗ |
| 2026-03-18 | Valente Manuela | Officer | — | — | Share Option (Right to Buy) | 10,000 | 3.20 | 32.0K | 0 | D | ↗ |
| 2026-03-18 | Puylaert Kevin | Officer | — | — | Share Option (Right to Buy) | 28,409 | 3.29 | 93.5K | 0 | D | ↗ |
| 2026-03-18 | Ossipow Vincent | Director | — | — | Share Option (Right to Buy) | 49,751 | 3.04 | 151.2K | 0 | D | ↗ |
| 2026-03-18 | Muken Ross | Officer | — | — | Share Option (Right to Buy) | 426,136 | 3.29 | 1.40M | 0 | D | ↗ |
| 2026-03-18 | Menu Philippe | Officer | — | — | Share Option (Right to Buy) | 52,000 | 6.31 | 328.1K | 0 | D | ↗ |
| 2026-03-18 | HIRSCH DIDIER | Director | — | — | Share Option (Right to Buy) | 49,751 | 3.04 | 151.2K | 0 | D | ↗ |
| 2026-03-18 | HIBBS KATHY L | Director | — | — | Share Option (Right to Buy) | 49,751 | 3.04 | 151.2K | 0 | D | ↗ |
| 2026-03-18 | Cox Troy | Director | — | — | Share Option (Right to Buy) | 162,740 | 4.12 | 670.5K | 0 | D | ↗ |
| 2026-03-18 | Cossery Jean-Michel | Director | — | — | Share Option (Right to Buy) | 49,751 | 3.04 | 151.2K | 0 | D | ↗ |
| 2026-03-18 | Camblong Jurgi | Director / Officer | — | — | Share Option (Right to Buy) | 1,005,682 | 3.29 | 3.31M | 0 | D | ↗ |
| 2026-03-18 | CARDOZA GEORGE | Officer | — | — | Share Option (Right to Buy) | 183,333 | 3.40 | 623.3K | 0 | D | ↗ |
| 2026-03-18 | Berkovitz Tomer | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-167.7K
Shares Outstanding
71.67M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jurgi Camblong | Co-Founder, Chief Executive Officer & Director | 1M | — |
| Daan van Well | Executive VP and Chief Legal & Compliance Officer | — | male |
| George A. Cardoza | Executive Vice President & Chief Financial Officer | — | male |
| Kellen Sanger | Head of Strategy and Investor Relations | — | — |
| Kevin Puylaert | SVP & Chief Sales Officer | — | male |
| Manuela Da Silva Valente | Executive Vice President & Chief People Officer | — | female |
| Philippe Menu | Executive Vice President, Chief Medical Officer & Chief Product Officer | — | — |
| Ross Jordan Muken | President | — | male |
| Abhimanyu Verma | EVP & Chief Technology Officer | — | male |
| Zhenyu Xu | Executive Vice President & Chief Scientific Officer | — | — |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SOPH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
